Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Instruments and Global Cell Solutions Collaborate at LabAutomation2010

Published: Friday, January 29, 2010
Last Updated: Friday, January 29, 2010
Bookmark and Share
Collaborators announce a new poster detailing the use of BioTek’s microplate instrumentation for various cell-based assays.

BioTek Instruments, Inc., and Global Cell Solutions, Inc., (GCS) announce a formal collaboration for the coming year at LabAutomation 2010.

The poster Automation of a Microplate Cell-based Assay to Measure Activity of the Histamine H1 G Protein-coupled Receptor Using a Novel 3-D Cell Culture Technique is the first in a series of collaborative publications detailing the use of BioTek’s microplate instrumentation for various cell-based assays.

The application poster details the use of BioTek’s MicroFlo™ Select Dispenser, Precision™ Automated Microplate Pipetting System and Synergy™ 4 Multi-Mode Microplate Reader with a novel 3-D cell culture method and FRET-based assay to measure activity of a Histamine H1 G protein-coupled Receptor. BioTek used the BioLevitator™ and GEM™ technologies to provide transformed cell types.

BioTek’s MicroFlo™ Select and Precision will be at booth 151 along with the successor to Synergy™ 4 and latest microplate technology – the Synergy™ H4 Hybrid Microplate Reader. The new Synergy™ H4 combines high-performance filter-based detection and flexible monochromator-based detection in one compact instrument. This hybrid of both technologies provides for endless flexibility in current and future microplate-based assay choice.

This collaboration is an opportunity to explore new paradigms for cell-based assay workflows and microplate-based screening of 3-D cell cultures. “Customers are using BioTek’s plate readers for cell-based assays to an increasing extent,” explains Peter Banks, Scientific Director at BioTek Instruments.

“We are particularly interested in collaborating with companies that provide novel enabling technologies such as the BioLevitator and GEM technologies for improving cell-based assay workflows. Being able to dispense cells directly into the assay without enzymatic detachment offers a workflow advantage and potential benefits to cell health and assay performance.” Future studies will include primary cell lines as well as kinase screening, ADME/Tox and live cell assays.

The BioLevitator utilizes the GEM technology, a magnetic culture particle that enables users to pipette transformed, primary and stem cells directly from culture to assay without enzymatic detachment and replating.

Looking forward to the new applications, Uday Gupta, President & CEO of GCS, commented, “We are thrilled to work with BioTek in validating popular cell-based assays using the GEM and BioLevitator. The newly released 3D-CellHOST™ will integrate the BioLevitator on the Hamilton STAR workstation to create a seamless automated workflow for unifying cell culture and cell-based assays.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioTek Continues International Growth with Launch of BioTek France
BioTek France team includes Dr. Dirk Frese, Philippe Vivier, Damien Brechet and Lionel Capelle.
Wednesday, January 25, 2012
BioTek Offers Service Through Serlabo in France
Serlabo will provide IQ/OQ/PQ, primary training, service, preventative maintenance and service contracts for users of BioTek's microplate instrumentation.
Friday, January 06, 2012
BioTek Recognized with 5x5x5 Award Again
BioTek receives the Award at the 9th annual awards ceremony on Thursday, September 15, 2011.
Saturday, September 17, 2011
BioTek Welcomes New Product Specialist to Cover Expanding Brazilian Market
BioTek Instruments, Inc. welcomes Marcus Stolarski to the company as Product Specialist. Marcus is responsible for supporting BioTek's distribution network and customers in Brazil.
Thursday, March 10, 2011
BioTek Instruments Announces Establishment of Korean Office
Managed by Mr. Yunki Kyung, the new direct sales and service organization will focus on growing BioTek's brand and expanding direct service and application support for our growing customer base in South Korea.
Tuesday, March 01, 2011
BioTek Announces New Applications and Business Development Manager in Canada
Dr Charles Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.
Monday, February 28, 2011
BioTek’s Synergy H1 Receives HTRF Certification
The latest addition to the patent-pending Hybrid Microplate Reader family has received HTRF® certification from Cisbio Bioassays.
Thursday, September 23, 2010
BioTek Instruments Launches International Web Sites
Company announces the availability of multi-lingual web sites for international customers.
Thursday, July 30, 2009
Introducing Scientifically Speaking - A Microplate Instrumentation Blog by BioTek Scientists
BioTek scientists are reaching out to the online community through their new blog providing general expertise for microplate instrumentation.
Thursday, July 16, 2009
BioTek Instruments Introduces new Web Site
The new web site, that soon will be available in multiple languages, has improved technical and application resources for life science and drug discovery markets.
Wednesday, February 25, 2009
DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
The DLR Assay System provides quantitation of firefly and Renilla luciferase reporters in transfected cells.
Wednesday, November 08, 2006
BioTek Delivers Support through Interactive Program
Qualified customers are introduced to the Winooski, VT facility with a brief plant tour.
Tuesday, September 12, 2006
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!